Elevated plasma homocyst(e)ine may predispose to complications of vascular disease. Homocysteine alters vasomotor regulatory and anticoagulant properties of cultured vascular endothelial cells, but little is known about effects of hyperhomocyst(e)inemia on vascular function in vivo. We tested the hypothesis that diet-induced moderate hyperhomocyst(e)inemia is associated with vascular dysfunction in cynomolgus monkeys. Plasma homocyst(e)ine increased from 4.0 Ϯ 0.2 M when monkeys were fed normal diet to 10.6 Ϯ 2.6 M when they were fed modified diet (mean Ϯ SE; P ϭ 0.02). Vasomotor responses were assessed in vivo by quantitative angiography and Doppler measurement of blood flow velocity. In response to activation of platelets by intraarterial infusion of collagen, blood flow to the leg decreased by 42 Ϯ 9% in monkeys fed modified diet, compared with 14 Ϯ 11% in monkeys fed normal diet ( P ϭ 0.008). Responses of resistance vessels to the endothelium-dependent vasodilators acetylcholine and ADP were markedly impaired in hyperhomocyst(e)inemic monkeys, which suggests that increased vasoconstriction in response to collagen may be caused by decreased vasodilator responsiveness to platelet-generated ADP. Relaxation to acetylcholine and, to a lesser extent, nitroprusside, was impaired ex vivo in carotid arteries from monkeys fed modified diet. Thrombomodulin anticoagulant activity in aorta decreased by 34 Ϯ 15% in hyperhomocyst(e)inemic monkeys ( P ϭ 0.03). We conclude that diet-induced moderate hyperhomocyst (
IntroductionModerate elevation of plasma homocyst(e)ine 1 concentration is associated with stroke, peripheral vascular disease, and myocardial infarction (1). Like hypercholesterolemia, hyperhomocyst(e)inemia is caused by both genetic and dietary factors and may possibly contribute to vascular disease in a large number of patients (2). Unlike hypercholesterolemia, hyperhomocyst(e)inemia has not been demonstrated to be a sufficient stimulus for development of atherosclerosis per se, but it appears to predispose to complications and perhaps progression of atherosclerosis. Plasma homocyst(e)ine concentration can be decreased by dietary supplementation with folic acid, which suggests that hyperhomocyst(e)inemia may be a treatable risk factor for vascular disease (1, 2).Mechanisms responsible for the association between hyperhomocyst(e)inemia and vascular disease are poorly understood. Results of studies with cultured endothelial cells suggest that homocysteine may impair vasomotor regulatory and antithrombotic properties of vascular endothelium. Exposure of cultured endothelial cells to homocysteine impairs nitric oxide-mediated inhibition of platelet aggregation (3) and inhibits thrombomodulin-dependent activation of protein C, a clinically important anticoagulant (4, 5). Homocysteine also induces cultured endothelial cells to express procoagulant molecules (6, 7) and alters binding of tissue plasminogen activator to endothelium (8). These effects of homocysteine in tissue culture suggest that endothelial dy...